V. Schoenau

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.

G. Schett, M. Englbrecht, E. Araujo, 2019, Seminars in arthritis and rheumatism.

Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease

T. Harrer, G. Schett, K. Tascilar, 2021, Annals of the Rheumatic Diseases.

COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses

M. Neurath, G. Schett, M. Sticherling, 2021, The Lancet Rheumatology.

Intensity and longevity of SARS-CoV-2 vaccination response and efficacy of adjusted vaccination schedules in patients with immune-mediated inflammatory disease

R. Atreya, A. Liphardt, G. Schett, 2022, medRxiv.

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

E. Naredo, D. Kofler, M. Feuchtenberger, 2024, The Lancet.